Results 111 to 120 of about 6,848 (153)

The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry. [PDF]

open access: yesJ Neurol
Guger M   +8 more
europepmc   +1 more source

Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS.

open access: yesJAMA Netw Open
Haggiag S   +86 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Cladribine

Reactions Weekly, 2022
Michelle C. Simpson, Eric G. Schaefer
  +5 more sources

Cladribine

Reactions Weekly, 2011
openaire   +2 more sources

Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study

Multiple Sclerosis and Related Disorders, 2023
Peter Vestergaard Rasmussen   +2 more
exaly  

Home - About - Disclaimer - Privacy